Privium Fund Management B.V. / VRTX
Privium Fund Management B.V.’s Vertex Pharmaceuticals Inc Position
Does Privium Fund Management B.V. own Vertex Pharmaceuticals Inc (VRTX)? Yes — 11.4K shares worth $5M (+1.06% of its 13F portfolio) as of Q1 2026, up from 9.4K shares the prior filed quarter.
Position Value
$5M
Q1 2026
Shares
11.4K
% of Portfolio
+1.06%
Quarters Held
14
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 11.4K | $5M | +1.06% |
| Q4 2025 | 9.4K | $4M | +0.78% |
| Q3 2025 | 8.3K | $3M | +0.58% |
| Q2 2025 | 8.3K | $4M | +0.81% |
| Q1 2025 | 8.3K | $4M | +1.05% |
| Q4 2023 | 15.1K | $6M | +1.73% |
| Q3 2023 | 21.4K | $7M | +2.21% |
| Q2 2023 | 30.9K | $11M | +3.10% |
| Q1 2023 | 32.5K | $10M | +3.44% |
| Q4 2022 | 35.3K | $10M | +3.87% |
| Q3 2022 | 28.5K | $8M | +3.03% |
| Q2 2022 | 28.0K | $8M | +2.61% |
| Q1 2022 | 28.0K | $7M | +1.62% |
| Q4 2021 | 31.0K | $7M | +1.37% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of VRTX.